slides · global inventory
Metric
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 79,264
Current window 26,431-26,460
Pages 2,643
Rows per page 30
Component
26,431-26,460 of 79,264
06
Data from L.E.K. 2023 APAC Hospital Priorities Survey (N=100).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
07
The slide uses a consistent color-coded legend for years (2021, 2022, 2023) across three bar charts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
08
NRDL = National Reimbursement Drug List. Data from L.E.K. APAC Hospital Priorities Survey.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a stacked bar chart approach to visualize survey data regarding prescription outflow shifts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
10
The chart shows a clear shift toward higher acceptance of digital engagement in 2023 compared to 2022 across all hospital segments.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
11
The slide uses a bilingual (Chinese/English) format for labels.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
12
Includes a specific callout explaining a spike in privacy concerns due to China's PIPL law.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
13
The slide uses a stacked bar chart approach to visualize survey responses regarding financial health.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
16
The slide uses a bilingual (English/Chinese) table format to present survey results from 100 respondents.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
17
The slide uses color coding to categorize priorities into Pandemic response, Workflow efficiency, and Care management capability.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
18
The table uses a 1-7 scale for survey responses; percentages represent respondents choosing 6 or 7.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
19
The slide uses a stacked bar chart approach to rank specialties by preference within each hospital category.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
20
The chart is a dot plot comparing three segments (Public L3, Public L2, Private) across 7 value drivers.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
21
Includes bilingual labels (English/Chinese).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
02
The slide provides a methodological overview of the survey sample, including familiarity, geography, sector, and functional role of respondents.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
05
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
The chart uses a grouped bar format to compare 'Before' and 'After' confidence scores (0-10 scale) with percentage change annotations.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
07
The chart uses a multi-select survey format, so percentages may not sum to 100%.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
08
The chart uses a custom layout with a central axis and directional arrows to indicate sentiment/impact.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
09
The chart displays multi-select survey data.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
10
The chart displays survey results regarding the impact of the US BIOSECURE Act on partnering intentions.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
09
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
18
The slide uses a multi-phase timeline framework to contextualize historical performance and future uncertainty.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
19
The slide uses a line chart to contrast Australia's containment success against the multi-wave patterns in other major nations.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
20
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
21
Dual-axis chart showing daily new cases by state and cumulative national cases.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
22
The slide uses a waterfall-style highlight for the COVID-19 impact period.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
23
Infrastructure beyond COVID-19Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit
24
The chart tracks three sentiment categories: appropriate, over-reacting, and not taking seriously enough.Infrastructure beyond COVID-19 · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Logic Chain1 hit